Rheum Advisor on Air

By Rheumatology Advisor

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store.

Category: Medicine

Open in Apple Podcasts

Open RSS feed

Open Website

Rate for this podcast

Subscribers: 7
Reviews: 0


In this series, we look at emerging topics in the field of rheumatology from various experts. These perspectives may be related to the diagnosis and treatment of rheumatic diseases, current guidelines, practice management, patient care, and much more. Rheum Advisor on Air is the official podcast of Rheumatology Advisor, a leading publication founded by the Haymarket Medical Network.

Episode Date
Gout Among Women: Not Just a “Man’s Disease”

Gout has often been known for its predominance among men. While it is true that risk for gout is 3 times higher among men vs women due to high uric acid levels, postmenopausal women especially form a significant percentage of a population with symptoms of unaddressed gout and a disproportionate worsening in disease burden.

For Arthritis Awareness Month and ahead of Gout Awareness Day, Angelo L. Gaffo, MD, discusses the importance of addressing the prevalence and impact of gout among women and improving provider and patient education in this regard.

May 20, 2022
It’s About Time We Took Chronic Pain Seriously

Pain – the main manifestation of many rheumatic diseases, but also the most underappreciated, leads to worse disease outcomes and affects the quality of life of patients.

Over the last decade or so, animal models and modern technology have highlighted the complex mechanisms that underlie chronic pain in rheumatology.

To get further insight on the various aspects of chronic pain, we speak with Don L. Goldenberg, MD, about its pathophysiology and diagnostic classification criteria for chronic pain conditions. Deeba Minhas, MD, provides a perspective on addressing implicit biases among patients with rheumatic disease and pain.

Apr 29, 2022
The Elephant in the Rheum – “Burnout” Among the Workforce

Feelings of stress, fatigue, and exhaustion – what is being described as “burnout” – have become a common occurrence among providers, including rheumatologists, with important implications in clinical practice. Various surveys and studies have reported a substantial prevalence of burnout (approximately 50%) among rheumatology providers.

Beth L. Jonas, MD, Reeves Foundation Distinguished Professor of Medicine and chief of the Division of Rheumatology, Allergy, and Immunology at the University of North Carolina at Chapel Hill, joins us on this episode to provide deeper insight on the issue of “burnout” from a clinical practice standpoint.

Mar 24, 2022
In Rare We Care: Pediatric Rheumatic Disease Awareness & Management

Juvenile idiopathic arthritis and lupus are the most common rheumatic diseases in children. However, more than 500,000 children develop other rheumatic diseases. The diagnosis, treatment, and management of these conditions often require a multidisciplinary approach owing to the diverse clinical manifestations that present in this patient population.

In light of Rare Disease Day 2022, we spoke with Emily von Scheven, MD, a pediatric rheumatologist at the University of California San Francisco Benioff Children's Hospital and the executive committee chair of CARRA, and Vincent Del Gaizo, director of partnerships and patient engagement for CARRA and a parent of a pediatric patient with rheumatic disease.

Feb 25, 2022
Patient Care at the Intersection of Rheumatology and Neurology

Rheumatologists and neurologists are known to manage and collaborate between their specialties in the care of patients with shared diagnoses, such as disorders of the central nervous system, like giant cell arthritis and neuropsychiatric lupus.

In this episode, done in collaboration with Neurology Advisor, neurologist Michael Kornberg, MD, and rheumatologist Laura C. Cappelli, MD, discuss the management of patients with rheumatologic conditions with neurologic manifestations, including defining the term "neurorheumatology," encouraging better collaboration between the 2 specialties, and improving access to care for this patient population.

Feb 10, 2022
Hear ye, hear ye: The Patient Voice in Rheumatology

The importance of patient perspectives, ie, the behaviors, concerns, and experiences of patients with rheumatic conditions, and patient-reported outcomes, were highlighted through several studies presented at the American College of Rheumatology (ACR) Convergence 2021.

In this episode, Shilpa Venkatachalam, PhD, MPH, and Betty Hsiao, MD, discuss research carried out by their respective teams emphasizing the role of the patient voice in rheumatology research and clinical practice. 

Jan 28, 2022
The Latest Gout Research at a Glance

The American College of Rheumatology (ACR) Convergence held in November 2021 included several important abstracts and sessions in gout research.

In this episode, Ada Kumar, MD, of Horizon Therapeutics, and Suneet Grewal, MD, of East Bay Rheumatology Medical Group, provide an overview of the compelling news and research in gout, as presented at the ACR annual meeting.

Jan 13, 2022
A Roundup of What’s Exciting in Lupus Research

There were several interesting research papers, posters, abstracts, and presentations on the diagnosis and treatment of lupus at the American College of Rheumatology (ACR) Convergence 2021, including the Great Debate that was about the use of voclosporin vs belimumab as add-on therapy in lupus nephritis.

Karen Costenbader, MD, provides a comprehensive roundup of all the exciting and compelling news and research in lupus, as presented at ACR annual meeting.

Dec 28, 2021
Rheum With a View: Management of JIA-Associated Uveitis in Adults

Uveitis has been recognized as the most common extra-articular manifestation and potentially sight-threatening complication of juvenile idiopathic arthritis (JIA). The most common form of JIA-associated uveitis (JIA-U) is chronic anterior uveitis, which is initially asymptomatic but may lead to visual disability. JIA-U can extend into adulthood and have significant ocular morbidity as well.

In this episode of the American College of Rheumatology (ACR) Convergence 2021 series, Mara Becker, MD, discusses the management of JIA-associated uveitis in adults, including collaboration with ophthalmologists, transition from pediatric rheumatology care, screening frequency, and treatment options.

Dec 16, 2021
What's the Buzz in Scleroderma?

There were some exciting and clinically meaningful research in scleroderma/systemic sclerosis presented by experts at the American College of Rheumatology (ACR) Convergence 2021.

Tracy Frech, MD, provides a comprehensive overview of the studies presented at the ACR meeting this year, by categorizing them into 5 categories: practice pearls, treatment updates, pediatrics, outcome measures, and COVID-19-related research.

Dec 09, 2021
Beyond Race and Ethnicity: Social Determinants of Health and Disparities in Rheumatology

Health care disparities in rheumatology have been shown to have a significantly negative effect on quality of life and patient outcomes. There are several factors that drive health inequities in the US, including race, ethnicity, and socioeconomics, such as education, health care access, and income.

In the first episode of the ACR Convergence 2021 series, we speak with rheumatologist Iris Y. Navarro-Millán, MD, who provides a deeper insight into understanding social determinants of health as drivers of health disparities in rheumatology and urges researchers and clinicians to look beyond just race and ethnicity when addressing these disparities.

Nov 23, 2021
Season 2: Rheum Advisor on Air

Stay tuned for season 2 of the Rheum Advisor on Air podcast!

Nov 12, 2021
The Past, Present, and Future of Lupus Treatments

The recent US Food and Drug Administration (FDA) approval of anifrolumab for the treatment of systemic lupus erythematosus (SLE) came a decade after the approval of human monoclonal antibody belimumab.

In this episode of the Rheumatology Advisor podcast, we speak with Mary K. Crow, MD, who provides a deeper insight into the evolution of lupus treatments over the years, with a focus on history, barriers in research, information regarding the anifrolumab approval, and the future of drug development in SLE.

We also present the perspectives of a patient with lupus; Christele Felix serves as a Patient Advocate for Lupus Studies (PAL) for the Lupus Research Alliance, provides peer support for those interested in learning about clinical trials in lupus, and has presented on various topics, including health disparities, at the American College of Rheumatology (ACR) annual conference.

Sep 09, 2021
COVID-19 & Rheumatic Disease: Are We in It for the Long Haul?

According to multiple studies and surveys, 50% to 80% of individuals continue to have lingering symptoms approximately 3 months after the onset of COVID-19. Now, musculoskeletal symptoms are becoming common lasting symptoms among “COVID-19 long haulers.”

In this episode of the Rheumatology Advisor podcast, guest hosts Tylar Stanley and Samiha Tamboo have a conversation with Swati Deshmukh, MD, a musculoskeletal radiologist at Beth Israel Deaconess Medical Center and assistant professor of radiology at Harvard Medical School, about “long COVID,” including evidence of musculoskeletal symptoms, and its effect on patients with rheumatologic disease.

Aug 05, 2021
The Breath-Taking Lungs and Scleroderma

An estimated 80% of patients with systemic sclerosis (SSc) have pulmonary involvement, with interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) being the most common of these lung manifestations. In fact, both these conditions have been identified as the leading causes of SSc-related mortality.

In this episode of the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress series, Toby Maher, MD, a professor of medicine and pulmonologist, describes the increased prevalence of lung involvement in scleroderma and the need for routine screening among these patients.

Jul 23, 2021
The Dish on Diet and Nutrition in Rheumatic Diseases

Research has shown the importance of diet and nutrition in reducing disease burden in rheumatic diseases, such as osteoarthritis, rheumatoid arthritis, and gout. But how can providers effectively communicate about the role of diet and nutrition to their patients with rheumatic and musculoskeletal diseases (RMDs)?

In this episode of the EULAR 2021 series, Elena Nikiphorou, MBBS/BSc, MD, discusses the importance of emphasizing diet and lifestyle, along with pharmacologic treatment, to patients with RMDs.

Jul 09, 2021
DMARDs: What Impact Do They Have on COVID-19 Outcomes in RA?

In the first episode of the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress series, we spoke with co-authors Jeffrey Sparks, MD, and Zachary Wallace, MD, about their research – the association between disease-modifying antirheumatic drug (DMARD) use and COVID-19 outcomes in rheumatoid arthritis (RA) – conducted on behalf of the COVID-19 Global Rheumatology Alliance.

The study was presented by Dr Sparks and Dr Wallace at the EULAR 2021 meeting and has been published in BMJ

Jun 29, 2021
Psoriasis and Psoriatic Arthritis: Providing Bidirectional Care

Owing to the overlap, and possible transition, of care between psoriasis, a systemic condition typically presenting as skin manifestations, and psoriatic arthritis (PsA), a chronic heterogeneous inflammatory arthritis, a multidisciplinary approach is required during patient management.

We’re joined on this episode by a dermatologist and rheumatologist, and Penn Medicine colleagues, Joel Gelfand, MD, and Alexis Ogdie, MD, who provide deeper insight into the overlap and transition of care between patients with psoriasis and PsA.

Jun 11, 2021
More Than Just a Pronoun: Ethics of Sex/Gender Assessment in Pediatrics

Pediatric rheumatologists and providers are uniquely positioned to build and foster relationships of trust with their patients. However, while providing care for the rheumatic condition, should physicians be allowed to inquire about the sexual orientation and gender identity of their patients?

In this episode, we tackle important questions about the ethical considerations during the development of treatment plans for pediatric patients with rheumatic diseases.

Karen Onel, MD, the chief of the Pediatric Rheumatology Division at the Hospital for Special Surgery, New York, along with third-year fellows in pediatric rheumatology Nayimisha Balmuri, MD, and Jacob Spitznagle, MD, speak with us about their clinical practice experiences and the importance of representing pediatric patients in a way that centers and considers their personhood holistically, especially among populations in which mental health issues and other psychosocial stressors are present.

May 26, 2021
The Rise of Big Data Registries in Rheumatology – Part 2

In part 1 of this series, experts provided insight into a few data registries in rheumatology, including ArthritisPower, CorEvitas, and the American College of Rheumatology (ACR)’s RISE registry.

In the second part, we’re discussing 2 more data registries in rheumatology. Yukiko Kimura, MD, provides an overview of the updates and future plans of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry for pediatric rheumatology; and Pedro Machado, MD, PhD, describes the engaging data and work stemming from the COVID-19 Global Rheumatology Alliance.

May 14, 2021
The Rise of Big Data Registries in Rheumatology – Part 1

The potential for big data and data registries in rheumatology is immense. In this 2-part series, we’re getting updates and the future plans of some of the big databases and data registries in rheumatology.

Michael George, MD, talks to us about ArthritisPower, Jeff Greenberg, MD, discusses the work of CorEvitas, and Christie Bartels, MD, provides further insight into the American College of Rheumatology (ACR)’s RISE Registry.

Apr 29, 2021
Mind the (Gender) Gap: Inequities Among Women in Academic Rheum

Recent studies have indicated the persistence of gender gaps in terms of promotion, publication, and federal funding in academic rheumatology in the United States, despite an increase in the number of women rheumatologists in the workforce over the years.

Authors of a paper published in Nature Reviews Rheumatology noted, “To move forward, we must find ways to address the gender gap in rheumatology with the goal of creating a workforce as diverse as the patient population it serves.”

In this episode, we are speaking with the authors, Shereen Mahmood, MD, and Irene Blanco, MD, to get further insight into the existing inequities among women in academic rheumatology, and how gender gaps can be bridged and parity achieved.

Apr 15, 2021
Thank “Gout” It’s Not True: Fictional Depictions in Film and TV

Messages and characters portrayed through film, television, and digital media have far-reaching effects and consequences on society. For many decades, the onscreen portrayal of gout has promoted inaccurate beliefs about its causes and management, such as self-indulgence and social status, as well as an association with humor, shame, and embarrassment. Subsequently, these misrepresentations have negatively affected the mental health and quality of life of patients with gout.

How can rheumatologists and providers address the issue?

This episode features Nehad Soloman, MD, a rheumatologist at Arizona Arthritis & Rheumatology Associates, and Christina Derksen, one of the study authors on a paper about the fictional depictions of gout in film and television, published in BMC Rheumatology.

Mar 26, 2021
Unraveling the Mysteries of Novel, Rare Rheumatic Diseases – Part 2

Inflammatory syndromes often have overlapping clinical manifestations, making them difficult to diagnose and categorize. Using a genome-first approach, researchers at the National Institutes of Health (NIH) have discovered an inflammatory disease called vacuoles, E1 enzyme, X-linked, autoinflammatory and somatic syndrome (VEXAS) that is caused by mutations in the UBA1 gene.

In this episode, Peter Grayson, MD, MSc, a study author on the recent paper published in the New England Journal of Medicine, gives us further insight into the discovery of the VEXAS syndrome and the overall importance of rare rheumatic disease research at the genetic and molecular level.

Mar 11, 2021
Rarest of Them All: Ultra-Rare Rheumatic Diseases – Part 1

Multisystem autoimmune rheumatic diseases are rare or ultra-rare disorders linked to significant mortality and morbidity. However, with the rise of new technology, including data registries and advanced genetic analysis, rare rheumatic disease research is being propelled forward to inform future therapeutic options and improve patient outcomes.

In light of Rare Disease Day 2021, Dr Jonathan Miner, MD, PhD, discusses his work and contributions to the rare disease space, and speaks to the importance of research and the management of patients with rare rheumatic diseases.

Feb 25, 2021
Rheuminating About COVID-19: A Rheumatologist’s Perspective

In the past year, coronavirus disease 2019 (COVID-19) has presented unique challenges to rheumatology practices and care. Although not at the frontline, rheumatologists have had to face difficult decisions regarding, and not limited to, immunosuppressant management and the continuity of care for patients. But with the COVID-19 vaccines at the helm, what does the current rheumatology landscape look like and what is potentially in store for the future of patient care?

In this episode, Amit Ladani, MD, a rheumatologist at West Virginia University Hospital, gives us his point-of-view.  

Editor’s Note: Please note that this episode was developed and edited before the American College of Rheumatology (ACR) released clinical guidance regarding COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases. We will be providing updated information soon.

Feb 12, 2021
Uncomplicating Pregnancies in Lupus and APS

Pregnancy for patients with antiphospholipid syndrome (APS) and lupus has historically been associated with complications, including increased risk for preeclampsia, fetal growth restriction, and fetal death, but outcomes have improved in the last 2 decades. However, identifying, predicting, and preventing the risk for pregnancy complications in this population still remains challenging.

Taking us on a deep dive into the subject is the 2020 recipient of the Rheumatology Research Foundation Shaun Ruddy Memorial Lectureship, Jane Salmon, MD, the Collette Kean Research Chair at the Hospital for Special Surgery and professor of medicine and obstetrics and gynecology at Weill Cornell Medicine, New York.

Jan 29, 2021
Make Rheum for Mental Health in Pediatric Rheumatology

There is a significant prevalence of mental health disorders among pediatric patients with rheumatic disease, increasing the risk for adverse outcomes not just in mental health, but also the underlying rheumatic condition. Pediatric rheumatologists, along with mental health professionals, are positioned to provide mental health screening and interventions for this patient population; however, it has been observed that there are significant gaps in the area of mental health in pediatric rheumatology.

Jan 15, 2021
Are We Underdiagnosing Large Vessel Vasculitis?

Imaging is an important aspect in the diagnosis and monitoring of large vessel vasculitides, including Takayasu and giant cell arteritis. However, traditional imaging modalities have consistently posed setbacks in terms of diagnostic accuracy for these conditions.

Our featured guest on this episode Anisha Dua, MD, gives us a brief insight into the various challenges observed with large vessel vasculitis imaging, particularly temporal artery biopsy, and how the inclusion of certain modalities, including ultrasound and magnetic resonance imaging (MRI), may improve diagnosis in these patients and our understanding of large vessel vasculitis.

Jan 07, 2021
Time for an Update: ACR RA Management Guidelines

To facilitate high-quality patient care and to include new and emerging evidence, the American College of Rheumatology (ACR) has developed and updated the guidelines for the management of rheumatoid arthritis (RA).

Our featured guest on this episode is Stanley Cohen, MD, who gives us a glimpse into the scope and new updates to the ACR guidelines, which are currently in the draft stage.

Dec 18, 2020
A Closer Look at Pegloticase Treatment in Gout

Approved by the US Food and Drug Administration for the treatment of refractory gout, pegloticase, in combination with immunomodulatory agents, is an area of gout treatment that has shown much promise. 

Our featured guest on this episode is Brian LaMoreaux, MD, MS, an investigator on many gout studies, who provides an overview of the notable research in pegloticase treatment in gout, as presented at the American College of Rheumatology (ACR) 2020 annual meeting.

Dec 10, 2020
Harnessing the Microbiome to Understand Rheumatic Diseases

There is growing evidence - both in animal models and humans - to suggest the significant role of the microbiome in the etiology of rheumatic diseases. Over the years, multiple microbial agents and changes in the composition of the microbiota have been associated with specific autoimmune diseases, only emphasizing the importance of the microbiome in rheumatology research today.

To give us further insight into this relevant topic, we are joined in this episode by Maximilian Konig, MD, of the Division of Rheumatology at the Johns Hopkins Hospital in Baltimore, Maryland, and Veena Taneja, PhD, associate professor of immunology in the Department of Immunology and Rheumatology at the Mayo Clinic in Rochester, Minnesota.

Oct 22, 2020
Let’s Talk Women’s Health in Rheumatic Diseases

Compared with men, women have a higher incidence of autoimmune disease and are more affected by rheumatic and musculoskeletal diseases (RMDs).

Therefore, in light of the American Medical Association (AMA)’s Women in Medicine Month, we’re highlighting the importance of recognizing women’s health in rheumatology. The American College of Rheumatology (ACR) also recently released guidelines for the management of reproductive health in women with RMDs.

Our featured guest is Mehret Birru-Talabi, MD, PhD, assistant professor of medicine and associate rheumatology fellowship program director in the Division of Rheumatology and Clinical Immunology at the University of Pittsburgh, Pennsylvania.

We will also be getting an expert input from lead author of the ACR guidelines on reproductive health in RMDs, Lisa Sammaritano, MD, attending physician, director of the Rheumatology Reproductive Health Program at the Barbara Volcker Center for Women and Rheumatic Disease in the Hospital for Special Surgery, New York, and professor of clinical medicine at Weill Cornell Medicine, New York.

Sep 17, 2020
Digital Health Technologies: The Future of Rheumatology Care

With the increase in remote monitoring of patients and the provision of telemedicine services during the coronavirus disease 2019 (COVID-19) pandemic, the role of digital health in medicine, as wearables, electronic health records, sensors, apps, and other technologies, has come to the forefront.

Especially in chronic care like rheumatology, the advent of digital health innovations and the digitization of healthcare has created new avenues for both clinicians and patients toward more efficient disease management and, in turn, potentially better health outcomes.

Our featured guests are W. Benjamin Nowell, PhD, MSW, director of patient-centered research at Global Healthy Living Foundation (GHLF) and CreakyJoints®, and Jeffrey Curtis, MD, MS, MPH, professor of medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham.

Sep 01, 2020
To Switch or Not to Switch: Biosimilars in Rheumatology

Although biosimilars have been proven to have equivalent efficacy and no clinically meaningful differences in safety and immunogenicity from their reference products, its use in rheumatology has generated much debate among clinicians, patients, drug manufacturers, and payers. While several of these biopharmaceuticals are still in the pipeline, biosimilars of originators, including adalimumab, etanercept, and infliximab have been approved for the treatment of patients with rheumatic diseases.

In this episode, we get further insight into the current state of biosimilars development and adoption in the United States vs other countries, interchangeability among adult and pediatric patients with rheumatologic conditions, nonmedical switching to biosimilars, and an overview of its potential cost benefits for the healthcare system.  

Our featured guest is Jonathan Kay, MD, professor of medicine and population and quantitative health sciences, Timothy S. and Elaine L. Peterson Chair in Rheumatology, and director of clinical research, Division of Rheumatology at the University of Massachusetts Medical School in Worcester, Massachusetts.

Aug 11, 2020
Into the Eye of the COVID-19 Cytokine Storm

In this episode, we get expert perspectives on the immunopathology and management of the cytokine storm in adult and pediatric patients with COVID-19.

Our featured guests are Scott W. Canna, MD, assistant professor of the departments of pediatrics and immunology at the University of Pittsburgh Children’s Hospital and Randy Q. Cron, MD, PhD, professor of pediatrics and medicine at the University of Alabama at Birmingham and director of the Division of Pediatric Rheumatology at Children's of Alabama.

Jul 24, 2020
Ethnic and Gender Disparities in Rheumatology Care: A Call to Action
Ethnic/racial and gender disparities remain deep-rooted in medicine and rheumatology today. In this episode and in what is one of the most pertinent topics of our times, we discuss and highlight the disproportionate burden of rheumatic diseases and coronavirus disease 2019 (COVID-19) in ethnic minorities and the gender disparities observed in rheumatology care before and during the COVID-19 pandemic.
How can rheumatologists and rheumatology professionals, in coalition with the patient community, address the issue of potential bias and the existing health disparities?
Our featured guests are Candace H. Feldman, MD, MPH, ScD and Rosalind Ramsey-Goldman, MD, DrPH, the authors of a recent article published in Arthritis and Rheumatology on the urgent action needed with regard to the widening disparities in patients with rheumatic diseases during COVID-19. 
Jul 09, 2020
Telerheumatology: The New Normal? Part 2

Telerheumatology is booming now, but will the use of technology persist after the coronavirus disease 2019 (COVID-19) pandemic resolves? Could it be the new normal?

In part 2 of this series, we’re getting perspectives from an allopathic and an osteopathic physician specializing rheumatology on the evolution of telemedicine and what the future may look like for the management of rheumatologic conditions. 

Our featured guest is Zsolt Kulcsar, DO, MPH, MBA, section chief at White Plains Hospital Physician Associates and physician lead of telehealth services and medical director at East Post Road Ventures in White Plains, New York.

Jun 18, 2020
Telerheumatology: The New Normal? Part 1

The coronavirus disease 2019 (COVID-19) pandemic has brought telehealth to the forefront of modern medicine. Telemedicine in rheumatology, or telerheumatology, may be the future of diagnosis and treatment in rheumatology. In this 2-part episode series, we’re delving deeper into the world of telerheumatology, and asking, “Could this be the new normal?”

Our featured guest is John K. Botson, MD, RPh, CCD, president of Alaska Rheumatology Alliance and rheumatologist at Orthopedic Physicians Alaska. 

Jun 09, 2020
How is COVID-19 Affecting the Health of Rheumatologists?

COVID-19 has not only had a negative influence on the health of individuals globally, but it has also mentally and physically affected healthcare professionals. In this first episode, also in light of Mental Health Awareness Month, we discuss the effect of the pandemic specifically on the health of rheumatologists and rheumatology providers, and how this, in turn, may have an impact on clinical practices and delivering patient care.

Featured guest is Max I. Hamburger, MD, Founder and Executive Chairman of United Rheumatology and Managing Partner of Rheumatology Associates of Long Island, as well as the President of the New York State Rheumatology Society. Dr. Hamburger can be reached at: maxhamburger@unitedrheumatology.com.

For more, visit RheumatologyAdvisor.com or follow us on Twitter.

May 13, 2020
Welcome to Rheum Advisor on Air

In this series, we look at emerging topics in the field of rheumatology from various experts. These perspectives may be related to the diagnosis and treatment of rheumatic diseases, current guidelines, practice management, patient care, and much more.

Rheum Advisor on Air is the official podcast of Rheumatology Advisor, a leading publication founded by the Haymarket Medical Network.

May 11, 2020